Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jun 26, 2024

BUY
$31.23 - $42.99 $31 - $42
1 New
1 $34,000
Q1 2024

May 13, 2024

BUY
$31.23 - $42.99 $93 - $128
3 New
3 $75,000
Q4 2023

Jun 26, 2024

SELL
$17.71 - $32.97 $53 - $98
-3 Closed
0 $12,000
Q4 2023

Feb 15, 2024

BUY
$17.71 - $32.97 $0 - $0
0 New
0 $0
Q3 2023

Nov 15, 2023

SELL
$25.44 - $37.35 $737 - $1,083
-29 Closed
0 $0
Q2 2023

Aug 08, 2023

BUY
$23.94 - $32.36 $694 - $938
29 New
29 $66,000
Q4 2022

Feb 15, 2023

BUY
$14.14 - $23.06 $240 - $392
17 New
17 $32,000

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $450M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Financial Gravity Asset Management, Inc. Portfolio

Follow Financial Gravity Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.